Roquette (France) has announced the successful completion of its acquisition of IFF Pharma Solutions.

With this acquisition, and following that of Qualicaps in 2023, Roquette said it strengthens its position as a key player in the health industry by integrating IFF Pharma Solutions’ expertise and innovative product portfolio. The transaction enhances Roquette’s ability to deliver high-value drug delivery solutions to pharmaceutical customers worldwide while reinforcing its commitment to innovation, according to the company.

“The successful acquisition of IFF Pharma Solutions marks a major step forward in our value-creation journey. We are thrilled to officially welcome our new colleagues as we start to write the next chapter of Roquette’s history,” said Pierre Courduroux, CEO of Roquette. “This pivotal move aligns perfectly with our strategic vision to provide innovative, high-quality excipients that improve the efficacy and safety of pharmaceutical formulations. By combining our strengths, Roquette is poised to become the pharmaceutical industry’s go-to partner for the development of drug delivery solutions that contribute to improving, sustaining, and saving patients’ lives.”

For more information, visit www.roquette.com.